NASDAQ:CLLS

Cellectis S.a Stock Forecast

etoro logo Buy CLLS
*Your capital is at risk
$2.75
-0.100 (-3.51%)
At Close: Jul 31, 2026
AI Analysis AI Analysis of CLLS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CLLS to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Cellectis S.A.
(Updated on Jul 31, 2026)

Sell candidate since Jul 27, 2026 Loss -4.84%

The Cellectis S.A. stock price fell by -3.51% on the last day (Friday, 31st Jul 2026) from $2.85 to $2.75. During the last trading day the stock fluctuated 6.74% from a day low at $2.67 to a day high of $2.85. The price has been going up and down for this period, and there has been a 4.56% gain for the last 2 weeks. Volume has increased on the last day by 9 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 13 thousand shares were bought and sold for approximately $34.70 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.44% during the next 3 months and, with a 90% probability hold a price between $1.70 and $2.11 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CLLS Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 5.77%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Cellectis S.A. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.83 and $2.92. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Cellectis S.A. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cellectis S.A. stock

Cellectis S.A. finds support from accumulated volume at $2.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.180 between high and low, or 6.74%. For the last week, the stock has had daily average volatility of 3.51%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLLS) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Cellectis S.A. to open at $2.76, and during the day (based on 14 day Average True Range), to move between $2.67 and $2.83, which gives a possible trading interval of +/-$0.151 (+/-5.65%) up or down from last closing price. If Cellectis S.A. takes out the full calculated possible swing range there will be an estimated 5.65% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.67 (2.91%) than the resistance at $2.98 (8.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Cellectis S.A. will release earnings AMC on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.263. We will update the financials statements for Cellectis S.A., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.36% in the first trading day after earnings release.

Is Cellectis S.A. stock A Buy?

Cellectis S.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.405 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $2.76 ( 0.242%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CLLS Performance

Trading levels for CLLS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.94 6.79%
R2 2.87 4.29%
R1 2.83 2.74%
Price 2.75
S1 2.69 -2.26%
S2 2.65 -3.80%
S3 2.58 -6.30%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.18 15.64%
R2 3.09 12.36%
R1 2.98 8.36%
Price 2.75
S1 2.67 -2.91%
S2 2.63 -4.36%
S3 2.60 -5.45%

FAQ

What is the symbol for Cellectis S.A. Stock and on which exchange is it traded?
The symbol for Cellectis S.A. is CLLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectis S.A. Stock?
Cellectis S.A. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cellectis S.A. Stock?
Cellectis S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectis S.A. Stock.

What's the current price of Cellectis S.A. Stock?
As of the end of day on the Jul 31, 2026, the price of an Cellectis S.A. (CLLS) share was $2.75.

What is the 52-week high and low for Cellectis S.A. Stock?
The 52-week high for Cellectis S.A. Stock is $5.48 and the 52-week low is $2.44.

What is the market capitalization of Cellectis S.A. Stock?
As of the Jul 31, 2026, the market capitalization of Cellectis S.A. is 276.147M.

When is the next earnings date for Cellectis S.A.?
The upcoming earnings date for Cellectis S.A. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT CELLECTIS S.A.
Cellectis S.A
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE